30
Views
2
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Do IFN-γ-release assays predict the risk of TB? New evidence from a study on patients with silicosis

&
Pages 1105-1108 | Published online: 10 Jan 2014

References

  • Leung CC, Yam WC, Yew WW et al. T-SPOT.TB outperforms tuberculin skin test in predicting tuberculosis disease. Am. J. Respir. Crit. Care Med. DOI: 10.1164/rccm.200912-1875OC (2010) (Epub ahead of print).
  • World Health Organization. Global Tuberculosis Control: Epidemiology, Strategy, Financing. WHO Report 2009. World Health Organization, Geneva, Switzerland (2009).
  • Lalvani A, Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br. Med. Bull.93, 69–84 (2010).
  • Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med.149(3), 177–184 (2008).
  • Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial IFN-γ release assays for detecting active TB: a metaanalysis. Chest137(4), 952–968 (2010).
  • Bakir M, Millington KA, Soysal A et al. Prognostic value of a T-cell-based, IFN-γ biomarker in children with tuberculosis contact. Ann. Intern. Med.149(11), 777–787 (2008).
  • Kik SV, Franken WP, Mensen M et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur. Respir. J.35(6), 1346–1353 (2010).
  • Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-γ assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med.177(10), 1164–1170 (2008).
  • Aichelburg MC, Rieger A, Breitenecker F et al. Detection and prediction of active tuberculosis disease by a whole-blood IFN-γ release assay in HIV-1-infected individuals. Clin. Infect. Dis.48(7), 954–962 (2009).
  • Hill PC, Jackson-Sillah DJ, Fox A et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One3(1), e1379 (2008).
  • Centers for Disease Control and Prevention. Updated guidelines for using IFN-γ release assays to detect Mycobacterium tuberculosis infection – United States, 2010. MMWR Recomm. Rep.59(No. RR-5), 1–25 (2010).
  • van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of IFN-γ assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One4(12), e8517 (2009).
  • Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-γ release assays for TB screening of healthcare workers: a systematic review. Am. J. Respir. Crit. Care Med.181, A1764 (2010).
  • Wallis RS, Pai M, Menzies D et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet375(9729), 1920–1937 (2010).
  • Goletti D, Carrara S, Butera O et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS One3(10), e3417 (2008).
  • Goletti D, Butera O, Vanini V et al. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur. Respir. J.36(1), 135–142 (2010).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.